Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

India Global Trial Hub Dreams Still Distant As Concerns Linger

Executive Summary

Indian clinical trial approvals appear to be on the downswing despite government moves to boost the troubled sector, as regulatory uncertainty and negative publicity continue to undermine confidence in the industry.


Related Content

Another Indian CRO Under EMA Lens Over Dirty Data Concerns
Indian Clinical Research Sector: Hope And Despair Amid Shutdowns
The ECG curse: India's Quest under lens in ''retrospective'' finding
Who's doing what on EMA call for generics suspension after Indian CRO data manipulation
Faced With An Adverse Verdict, India’s Clinical Research Industry Pushes For A Quick Makeover


Related Companies